Free Trial
NASDAQ:CTCX

Carmell (CTCX) Stock Price, News & Analysis

Carmell logo
$4.06 -0.10 (-2.40%)
As of 07/24/2025

About Carmell Stock (NASDAQ:CTCX)

Key Stats

Today's Range
$4.05
$4.22
50-Day Range
$2.27
$5.78
52-Week Range
$0.17
$1.27
Volume
42,154 shs
Average Volume
4.65 million shs
Market Capitalization
$84.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CTCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carmell and its competitors with MarketBeat's FREE daily newsletter.

CTCX Stock News Headlines

XAGE Longevity Health Holdings, Inc.
The Private Market Surge Is Coming in 2025
The most lucrative investment opportunities are reserved for a select category of investor. They're private. They're quiet. And they're often available exclusively to accredited investors operating outside the noise of the public markets. We're talking about off-market placements, early venture deals, private credit, and pre-IPO shares—the kind of plays that can generate outsized gains before Wall Street catches wind. Here's the reality: having access is only the beginning. These deals can be opaque, rushed, and filled with hidden risk. That's why we created something exclusively for investors like you—the 2025 Accredited Investor Playbook.
Carmell Therapeutics rebrands to Longevity Health Holdings
Carmell Therapeutics files $100M mixed securities shelf
Carmell Therapeutics closes acquisition of Elevai Skincare
See More Headlines

CTCX Stock Analysis - Frequently Asked Questions

Carmell's stock was trading at $0.2791 on January 1st, 2025. Since then, CTCX shares have increased by 1,354.7% and is now trading at $4.06.

Shares of CTCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Carmell investors own include Sangamo Therapeutics (SGMO), abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), Meta Platforms (META), NVIDIA (NVDA), Blue Owl Capital (OBDC) and Tenax Therapeutics (TENX).

Company Calendar

Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CTCX
CIK
1842939
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.44 million
Net Margins
N/A
Pretax Margin
-29,527.27%
Return on Equity
-217.50%
Return on Assets
-50.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.31
Quick Ratio
0.29

Sales & Book Value

Annual Sales
$32.84 thousand
Price / Sales
2,584.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.07 per share
Price / Book
3.79

Miscellaneous

Outstanding Shares
20,905,000
Free Float
14,843,000
Market Cap
$84.87 million
Optionable
Not Optionable
Beta
0.51
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CTCX) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners